Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibition of SF3B1 by molecules targeting the spliceosome results in massive aberrant exon skipping
Gang Wu, Liying Fan, Michael N. Edmonson, et al.
RNA (2018) Vol. 24, Iss. 8, pp. 1056-1066
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Pan-neuroblastoma analysis reveals age- and signature-associated driver alterations
Samuel W. Brady, Yanling Liu, Xiaotu Ma, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 130
Aberrant splicing isoforms detected by full-length transcriptome sequencing as transcripts of potential neoantigens in non-small cell lung cancer
Miho Oka, Liu Xu, Toshihiro Suzuki, et al.
Genome biology (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 88
Zika virus noncoding sfRNAs sequester multiple host-derived RNA-binding proteins and modulate mRNA decay and splicing during infection
Daniel Michalski, J. Gustavo Ontiveros, Joseph Russo, et al.
Journal of Biological Chemistry (2019) Vol. 294, Iss. 44, pp. 16282-16296
Open Access | Times Cited: 76
Alternative RNA splicing modulates ribosomal composition and determines the spatial phenotype of glioblastoma cells
Tatyana Larionova, Soniya Bastola, Tatiana E. Aksinina, et al.
Nature Cell Biology (2022) Vol. 24, Iss. 10, pp. 1541-1557
Open Access | Times Cited: 46
Targeted high-throughput mutagenesis of the human spliceosome reveals its in vivo operating principles
Irene Beusch, Beiduo Rao, Michael Studer, et al.
Molecular Cell (2023) Vol. 83, Iss. 14, pp. 2578-2594.e9
Open Access | Times Cited: 25
m6A-driven SF3B1 translation control steers splicing to direct genome integrity and leukemogenesis
Maciej Cieśla, Phuong Cao Thi Ngoc, Sowndarya Muthukumar, et al.
Molecular Cell (2023) Vol. 83, Iss. 7, pp. 1165-1179.e11
Open Access | Times Cited: 24
Spliceosome component SF3B1 as novel prognostic biomarker and therapeutic target for prostate cancer
Juan M. Jiménez‐Vacas, Vicente Herrero‐Aguayo, Enrique Gómez‐Gómez, et al.
Translational research (2019) Vol. 212, pp. 89-103
Closed Access | Times Cited: 70
Splicing modulators: on the way from nature to clinic
Tilman Schneider‐Poetsch, Jagat K Chhipi-Shrestha, Minoru Yoshida
The Journal of Antibiotics (2021) Vol. 74, Iss. 10, pp. 603-616
Open Access | Times Cited: 43
Therapeutic Targeting of Alternative Splicing: A New Frontier in Cancer Treatment
Anthony Murphy, Alex H. Li, Peichao Li, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 34
Update on uveal melanoma: Translational research from biology to clinical practice (Review)
Miguel Á. Ortega, Oscar Fraile‐Martínez, Natalio García‐Honduvilla, et al.
International Journal of Oncology (2020) Vol. 57, Iss. 6, pp. 1262-1279
Open Access | Times Cited: 50
SF3B1 homeostasis is critical for survival and therapeutic response in T cell leukemia
Cuijuan Han, Alireza Khodadadi‐Jamayran, Adam H. Lorch, et al.
Science Advances (2022) Vol. 8, Iss. 3
Open Access | Times Cited: 25
Zygotic Splicing Activation of the Transcriptome is a Crucial Aspect of Maternal‐to‐Zygotic Transition and Required for the Conversion from Totipotency to Pluripotency
Hua Zhang, Yang Wang, Zhe‐Wei Hu, et al.
Advanced Science (2024) Vol. 11, Iss. 14
Open Access | Times Cited: 5
Inhibition of SF3b1 by pladienolide B evokes cycle arrest, apoptosis induction and p73 splicing in human cervical carcinoma cells
Qianjing Zhang, Cuixia Di, Junfang Yan, et al.
Artificial Cells Nanomedicine and Biotechnology (2019) Vol. 47, Iss. 1, pp. 1273-1280
Open Access | Times Cited: 41
Current Treatment of Uveal Melanoma
Katie Hanratty, Gráinne Finegan, Keith D. Rochfort, et al.
Cancers (2025) Vol. 17, Iss. 9, pp. 1403-1403
Open Access
A common cellular response to broad splicing perturbations is characterized by metabolic transcript downregulation driven by the Mdm2–p53 axis
Jade E. Varineau, Eliezer Calo
Disease Models & Mechanisms (2024) Vol. 17, Iss. 2
Open Access | Times Cited: 3
Disease modeling of core pre-mRNA splicing factor haploinsufficiency
K Wood, Charlie F Rowlands, Wasay Mohiuddin Shaikh Qureshi, et al.
Human Molecular Genetics (2019) Vol. 28, Iss. 22, pp. 3704-3723
Open Access | Times Cited: 21
Modelling the developmental spliceosomal craniofacial disorder Burn-McKeown syndrome using induced pluripotent stem cells
K Wood, Charlie F Rowlands, Huw B. Thomas, et al.
PLoS ONE (2020) Vol. 15, Iss. 7, pp. e0233582-e0233582
Open Access | Times Cited: 20
Splicing modulators elicit global translational repression by condensate-prone proteins translated from introns
Jagat K Chhipi-Shrestha, Tilman Schneider‐Poetsch, Takehiro Suzuki, et al.
Cell chemical biology (2021) Vol. 29, Iss. 2, pp. 259-275.e10
Open Access | Times Cited: 16
Therapeutic approaches to treat human spliceosomal diseases
Anthony B. DeNicola, Yi Tang
Current Opinion in Biotechnology (2019) Vol. 60, pp. 72-81
Open Access | Times Cited: 19
CRISPR editing of sftb-1/SF3B1 in Caenorhabditis elegans allows the identification of synthetic interactions with cancer-related mutations and the chemical inhibition of splicing
Xènia Serrat, Dmytro Kukhtar, Eric Cornes, et al.
PLoS Genetics (2019) Vol. 15, Iss. 10, pp. e1008464-e1008464
Open Access | Times Cited: 18
An exon skipping screen identifies antitumor drugs that are potent modulators of pre-mRNA splicing, suggesting new therapeutic applications
Yihui Shi, Walter M. Bray, Alexander J. Smith, et al.
PLoS ONE (2020) Vol. 15, Iss. 5, pp. e0233672-e0233672
Open Access | Times Cited: 17
Branchpoints as potential targets of exon-skipping therapies for genetic disorders
Hiroaki Ohara, Motoyasu Hosokawa, Tomonari Awaya, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 33, pp. 404-412
Open Access | Times Cited: 6
Metabolic reprogramming of cancer cells by JMJD6-mediated pre-mRNA splicing associated with therapeutic response to splicing inhibitor
Carolyn M. Jablonowski, Waise Quarni, Shivendra V. Singh, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 6
A cell-based splicing reporter system to identify regulators of cis-splicing between adjacent genes
Katarzyna Chwalenia, Fujun Qin, Sandeep Singh, et al.
Nucleic Acids Research (2018) Vol. 47, Iss. 4, pp. e24-e24
Open Access | Times Cited: 18
Knockdown of SF3B1 inhibits cell proliferation, invasion and migration triggering apoptosis in breast cancer via aberrant splicing
Ling Zhang, Xiaojuan Zhang, Haitao Zhang, et al.
Breast Cancer (2020) Vol. 27, Iss. 3, pp. 464-476
Closed Access | Times Cited: 16
Page 1 - Next Page

Scroll to top